Comparison of Preemptive Analgesic Effects of Dexketoprofen Versus Dexmedetomidine on Abdominal Hysterectomy Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of this study is to investigate comparison of preemptive analgesic effects of dexketoprofen versus dexmedetomidine on the patients that is undergoing abdominal hysterectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4 pain
Started Mar 2014
Shorter than P25 for phase_4 pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 18, 2014
CompletedFirst Posted
Study publicly available on registry
March 19, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedMarch 21, 2014
March 1, 2014
3 months
March 18, 2014
March 20, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analog Scale
Visual Analog Scale on rest and movement record
postoperative 1 day
Secondary Outcomes (1)
analgesic consumption
postoperative 1 day
Study Arms (2)
dexketoprofen trometamol
ACTIVE COMPARATORıv 50 mg dexketoprofen trometamol after anesthesia induction
dexmedetomidine
ACTIVE COMPARATORıv 1 mcg/kg dexmedetomidine after anaesthesia induction
Interventions
ıv 50 mg dexketoprofen trometamol after anaesthesia induction
ıv 1 mcg/kg dexmedetomidine after anaesthesia induction
Eligibility Criteria
You may qualify if:
- year female
- Scheduled for elective abdominal hysterectomy
- No known allergies to drugs
- ASA I-II patients
You may not qualify if:
- Pregnancy
- Drug or alcohol abuse
- History of allergic reaction to any of the study drugs
- Ongoing opioid, and non-steroidal anti-inflammatory
- Analgesic therapy
- Cardiac, respiratory, hepatic and/or renal failure
- History of peptic ulcer disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erciyes Univercity Medicine Faculty
Kayseri, 38039, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
selda kayaaltı, resident
erciyes univercity medicine faculty
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident
Study Record Dates
First Submitted
March 18, 2014
First Posted
March 19, 2014
Study Start
March 1, 2014
Primary Completion
June 1, 2014
Study Completion
July 1, 2014
Last Updated
March 21, 2014
Record last verified: 2014-03